Medication Potency: How Temperature, Time & Storage Affect Medicines

A medicine can still be within its expiration date and yet be affected by improper storage.

Temperature is one of the factors that can influence drug stability. Excessive heat can accelerate degradation, while freezing can damage certain medicines and biological products. But temperature alone does not tell the whole story.

The type of medicine, formulation, packaging, temperature reached, and length of exposure all matter.

That is why a medicine exposed to a high temperature for a short period cannot automatically be treated the same way as the same product stored under excessive heat for weeks.

This distinction matters in pharmaceutical quality control, but it also matters at home. A medicine left in a hot car, exposed to direct sunlight, or accidentally frozen may need a closer look before it is used.

Affiliate Disclosure: Some links in this article are affiliate links. As an Amazon Associate I earn from qualifying purchases.

What Is Medication Potency?

Potency refers to how much active pharmaceutical ingredient is present in a medicine relative to its established specification.

For example, if a tablet is manufactured to contain a specific amount of an active ingredient, its potency is assessed through appropriate testing to determine whether the amount remains within the approved specification.

Potency is related to, but not identical to, stability.

A medicine may undergo chemical or physical changes during storage before a clinically meaningful loss of potency is established.

This is why pharmaceutical stability testing looks at more than one measurement.

Depending on the product, stability programs may evaluate:

• assay or potency
• degradation products
• impurities
• dissolution
• appearance
• physical properties
• microbiological quality
• other product-specific characteristics

ICH Q1A explains that stability testing should examine attributes that are susceptible to change during storage and could affect quality, safety, or efficacy. Stress testing can also help identify degradation pathways and potential degradation products.

What Causes Medication Potency Loss?

Temperature is only one possible cause.

Other factors can contribute to medication degradation or instability, including:

1. Excessive Heat

Higher temperatures can accelerate chemical reactions. Depending on the drug molecule and formulation, this can increase degradation and reduce the amount of active ingredient available.

FDA notes that high-temperature storage can increase degradation products in some oral liquid medicines.

2. Freezing

Freezing can damage some medicines even when heat is not involved.

The effect depends heavily on the formulation. Certain vaccines, for example, can permanently lose potency after freezing.

3. Moisture

Humidity can affect products that are sensitive to water.

Tablets and capsules can be particularly vulnerable when their packaging does not adequately protect them from moisture.

4. Light

Some active ingredients and formulations are sensitive to light. That’s one reason certain medicines are supplied in light-protective containers.

5. Oxygen

Oxidation can contribute to degradation of susceptible drug substances and formulations.

6. Time

Even under appropriate storage conditions, medicines are not chemically frozen in time.

Stability studies are used to establish how long a product can maintain its required quality under specified conditions.

How Temperature Affects Medication Potency

Temperature can influence the rate at which chemical and physical changes occur.

A simplified way to think about it is:

Higher temperature + sufficient exposure time → potentially faster degradation

But that does not mean:

Higher temperature = immediate loss of potency

The relationship depends on the individual product.

A pharmaceutical manufacturer studies these characteristics during development and stability testing. ICH stability guidance includes temperature stress as part of understanding degradation pathways.

This is also why pharmaceutical storage instructions are product-specific rather than universal.

Real Product Examples: What Temperature Can Actually Do to Medicines

This is where the issue becomes easier to understand.

1. Insulin: Heat and Freezing Can Reduce Effectiveness

Insulin is one of the clearest real-world examples of a temperature-sensitive medicine.

FDA states that extreme temperatures can make insulin less effective and that the longer insulin is exposed to extreme heat or cold, the greater the potential reduction in effectiveness. FDA also specifically advises not to use insulin that has been frozen.

At the same time, insulin products do not all have identical storage instructions.

For example, FDA’s current emergency guidance notes that certain unopened or in-use insulin products can remain at room temperature within defined limits for a specified period. The exact conditions depend on the insulin product.

The lesson: don’t apply one temperature rule to every insulin product.

Follow the specific product’s prescribing information.

Recommended travel option:  INSULIN COOLER AMAZON AFFILIATE LINK HERE

2. Vaccines: Freezing Can Permanently Reduce Potency

Vaccines provide another important example.

CDC states that failure to follow recommended vaccine storage and handling conditions can reduce or destroy potency.

For refrigerator-stored vaccines, CDC identifies a particularly important problem: liquid vaccines containing aluminum adjuvants can permanently lose potency when exposed to freezing temperatures.

This is a good reminder that “cold” is not automatically safer than “warm.”

A product designed for refrigeration may still be damaged if it freezes.

CDC also emphasizes that assessing an out-of-range vaccine temperature involves considering both the magnitude and duration of the excursion.

3. MenAfriVac: A Powerful Example of Why Temperature and Time Matter Together

There is an interesting example from the WHO that shows why blanket statements about temperature can be misleading.

MenAfriVac, a meningitis A vaccine, was evaluated for use in a controlled temperature chain (CTC).

WHO reported that the vaccine was licensed for a controlled-temperature-chain approach allowing it to be kept at temperatures up to 40°C for up to four days under specified, monitored conditions.

That does not mean vaccines can generally be stored at 40°C.

It means that this particular vaccine had stability data supporting a specific, approved temperature-and-time condition.

This is an important pharmaceutical principle:

A temperature excursion has to be interpreted in the context of the product’s stability data.

WHO’s CTC guidance also uses vaccine vial monitors and other temperature-monitoring tools to help determine whether heat exposure has remained within the permitted conditions.

What About Tablets and Oral Medicines?

People often assume tablets are automatically stable because they look solid.

That’s not necessarily true.

FDA guidance on oral solutions and suspensions notes that storage at high temperatures may increase degradation products and that storage limitations involving time and temperature should be scientifically justified.

Solid medicines can also experience chemical or physical changes depending on the active ingredient, formulation, packaging, humidity, and storage temperature.

For a practical example of how one commonly used oral medicine is used, see our guide to aspirin and other oral medicines.

The important point is that appearance alone cannot establish potency.

A tablet can look normal and still require analytical testing to determine whether its chemical quality remains within specification.

Real Pharmaceutical Example: Heat Can Increase Degradation Products

This is where the pharmaceutical QC perspective becomes particularly useful.

FDA’s stability guidance explains that degradation products are chemical substances formed when a drug molecule changes over time or under influences such as temperature, light, water, pH, or interactions with excipients or the container-closure system.

FDA has also described actual drug-product stability investigations where elevated temperatures produced identifiable degradation products.

For example, an FDA chemistry review of an empagliflozin/metformin extended-release product reported degradation products for empagliflozin under elevated-temperature and accelerated stability conditions.

The important point isn’t that every tablet will behave the same way.

It is that temperature can change the chemical profile of a drug product, and pharmaceutical stability testing is designed to detect and characterize those changes.

Biologic Medicines Are Especially Temperature-Sensitive

Biological medicines create another layer of complexity.

Many biologics contain proteins or other large biological molecules whose structure is important for their biological activity.

FDA’s ICH Q5C guidance explains that biological products can be particularly sensitive to environmental factors including:

• temperature changes
• oxidation
• light
• ionic conditions
• mechanical stress

Maintaining molecular structure is important because structural changes can affect biological activity and contribute to degradation.

This is one reason biologic medicines often have carefully controlled storage and transportation requirements.

Why Time Matters as Much as Temperature

A common mistake is to ask only:

“How hot did the medicine get?”

The better question is:

“How hot did it get, and for how long?”

A short excursion and prolonged exposure may not have the same effect.

Consider two hypothetical situations:

Scenario A:
A medicine briefly reaches a temperature outside its labelled range during transportation.

Scenario B:
The same medicine remains substantially above its labelled storage temperature for several weeks.

Those two events should not automatically be treated as equivalent.

FDA’s stability guidance emphasizes the importance of actual temperature and humidity conditions when assessing stability.

This is why pharmaceutical manufacturers use stability data rather than a simple “hot or cold” rule.

What Is a Temperature Excursion?

A temperature excursion occurs when a temperature-sensitive product is exposed to conditions outside its specified storage range.

For example, a medicine labelled for refrigerated storage might experience an excursion if the refrigerator temporarily becomes too warm.

But an excursion is an event to evaluate, not automatically a declaration that the product has failed.

The assessment may consider:

1. What was the labelled storage range?
2. What temperature was actually reached?
3. How long did the exposure last?
4. Was the exposure continuous or intermittent?
5. What formulation is involved?
6. What does the manufacturer’s stability data show?
7. Were degradation products or other quality attributes potentially affected?

CDC uses this approach for vaccines, noting that viability decisions after out-of-range temperatures should consider both the time and magnitude of the excursion and involve the manufacturer or appropriate public-health authority.

A Real FDA Temperature-Excursion Case

Temperature control is not just a theoretical issue.

In a September 2026 FDA warning letter, the agency documented concerns at a drug facility where temperature records showed storage areas exceeding labelled conditions for extended periods.

FDA requested a retrospective assessment of affected products, including evaluation of potential impact on product quality, safety and efficacy and the possible formation of impurities and degradation products.

That is exactly how temperature is treated in pharmaceutical quality systems.

The question is not simply:

“Was the warehouse too warm?”

The quality question is:

“What was the potential impact on the products stored there?”

That distinction matters.

Can You Tell If a Medicine Has Lost Potency by Looking at It?

Usually, no.

A medicine may show obvious physical changes such as:

• discoloration
• melting
• cracking
• separation
• unusual texture
• swelling
• precipitation

But the absence of visible changes does not prove that the chemical potency is unchanged.

A product can look normal while still requiring analytical testing to determine its assay or degradation profile.

In pharmaceutical laboratories, stability-indicating analytical methods are used to distinguish the active ingredient from relevant degradation products and other components. FDA notes that such methods need to be appropriately reliable, meaningful and specific.

This is one reason consumers should not try to estimate a medicine’s remaining potency from appearance alone.

How Is Medication Potency Tested?

The exact testing depends on the medicine.

Pharmaceutical laboratories may use validated analytical methods to evaluate attributes such as:

• assay
• related substances
• degradation products
• dissolution
• content uniformity
• physical properties
• biological activity for certain products

For some drug substances and products, HPLC is an important analytical technique for measuring the active ingredient and related degradation products.

Forced-degradation studies may deliberately expose a product to stress such as elevated temperature, humidity, oxidation, light or extreme pH.

The purpose is not to simulate normal storage.

It is to understand how the product can degrade and whether the analytical method can detect those changes.

ICH Q1A specifically describes stress testing as a tool for identifying degradation products and degradation pathways.

For readers interested in how pharmaceutical laboratories evaluate analytical data, see our guide to HPLC Audit Trail Review: Applying ALCOA+ Principles in Pharmaceutical QC.

What Should You Do If Medicine Gets Too Hot?

Don’t automatically assume it is ruined.

Instead:

1. Check the label

Look for the manufacturer’s storage instructions.

2. Identify the actual exposure

Try to determine:

• approximate temperature
• duration
• whether the product was exposed to direct sunlight
• whether it was frozen
• whether the packaging remained intact

3. Don’t guess based on appearance

A normal-looking tablet or injection does not prove that potency is unchanged.

4. Contact a pharmacist or manufacturer

This is particularly important for:

• insulin
• vaccines
• biologics
• refrigerated medicines
• injectable medicines
• medicines needed for serious conditions

5. Don’t automatically throw away the medicine

A temperature excursion does not automatically mean the product is unusable.

The appropriate decision depends on the specific medicine and available stability information.

What About Medicine Left in a Hot Car?

A parked vehicle can reach temperatures far above the surrounding outdoor temperature.

That makes a car a poor storage environment for temperature-sensitive medicines.

If medication has been left in a hot car, don’t assume that every product has been damaged—and don’t assume that every product is still safe.

Check the product’s storage requirements and ask a pharmacist or manufacturer when the exposure was substantial or the medication is temperature-sensitive.

This is particularly important for insulin, biologics, vaccines and other medicines with specific temperature requirements.

How to Store Medicines Safely

The simplest rule is also the most important:

Follow the storage conditions on the medicine’s label or package insert.

In general:

• Keep medicines away from direct sunlight unless the product instructions say otherwise.
• Avoid unnecessary exposure to heat.
• Don’t freeze medicines unless the product specifically requires frozen storage.
• Don’t automatically refrigerate a medicine just because it feels safer.
• Keep medicines in their original packaging when appropriate.
• Keep moisture-sensitive medicines away from humid environments.
• Avoid storing medicines in places with large temperature fluctuations.
• Keep temperature-sensitive medicines monitored during transportation when required.

For organizing medicines during travel: GDNASIST MEDICINE STORAGE BAG AMAZON 

Storage conditions are part of the product’s stability specification—not just a suggestion printed on the box. FDA states that expiration dating reflects stability when the product is stored according to its labelled conditions.

For broader pharmaceutical quality context, see Pharmaceutical Quality Control: How Drug Quality Is Built & Tested.

Does Expiration Mean a Medicine Suddenly Loses Potency?

No.

A medicine does not necessarily become ineffective at midnight on its expiration date.

The expiration date represents the period during which the manufacturer has established, through stability data, that the product remains within its required quality attributes when stored under the specified conditions.

But improper storage creates another problem.

FDA notes that a medicine that has degraded because it was not stored according to labelled conditions may have reduced strength or, depending on the degradation pathway, may produce unwanted degradation compounds.

So these are two different questions:

Question 1: Has the labelled expiration date passed?

Question 2: Was the medicine stored under the conditions required to support its labelled shelf life?

Both matter.

The Key Pharmaceutical Principle: Temperature Is Not the Whole Story

If there is one concept to remember from this article, it is this:

Drug stability is influenced by more than temperature alone.

A useful way to think about it is:

Temperature + Time + Formulation + Packaging + Environment = Stability Risk

The same temperature can have different consequences for different medicines.

The same medicine can also respond differently to a short excursion versus prolonged exposure.

That’s why pharmaceutical manufacturers generate product-specific stability data rather than relying on one universal temperature rule.

Quick Summary

• Temperature can affect medication potency and stability.
• Excessive heat can accelerate degradation in susceptible medicines.
• Freezing can permanently damage some products.
• Insulin is a clear example of a temperature-sensitive medicine.
• Some vaccines can permanently lose potency after freezing.
• MenAfriVac demonstrates that some vaccines can tolerate defined higher temperatures for limited periods when supported by stability data and approved CTC conditions.
• Biologic medicines can be particularly sensitive to temperature changes.
• Time matters alongside temperature.
• A temperature excursion does not automatically mean a medicine has failed.
• Appearance alone cannot reliably determine medication potency.
• Pharmaceutical laboratories use stability-indicating analytical methods to detect potency changes and degradation products.
• The medicine’s own labelled storage requirements should always take priority.

Frequently Asked Questions

Can heat reduce medication potency? +

Yes. Excessive heat can accelerate degradation in susceptible medicines and may reduce potency. The effect depends on the product, temperature and duration of exposure.

Can freezing make medicine ineffective? +

For some medicines, yes. Certain vaccines can permanently lose potency after freezing, and FDA advises against using insulin that has been frozen.

How long can medicine stay outside its recommended temperature? +

There is no universal time limit.

Some medicines have specific allowable excursion conditions, while others may be highly temperature-sensitive. The product label, manufacturer stability information and pharmacist/manufacturer guidance should be used.

Can you tell whether a medicine lost potency by looking at it? +

No. Visible changes may indicate a problem, but a normal appearance does not prove that chemical potency is unchanged.

Does medication lose potency immediately after its expiration date? +

Not necessarily. Expiration dating is based on stability data under specified storage conditions. It should not be interpreted as an instantaneous chemical failure point.

Is refrigerated storage always better? +

No.

Some medicines require refrigeration, while others are intended for room-temperature storage. Refrigerating a product that should not be refrigerated can also create problems, particularly if the product freezes.

What should I do if my medicine was exposed to extreme heat? +

Check the labelled storage requirements and contact a pharmacist or the manufacturer if the exposure was significant. Do not rely only on appearance to decide whether the medicine is still potent.

Bottom Line

Temperature can affect medication potency, but “heat ruins medicine” is too simple a statement.

The real issue is stability.

Heat can accelerate degradation. Freezing can damage certain formulations. Time determines how long those conditions act on the product. Packaging and formulation can change the outcome. And some products have stability data showing that they can tolerate defined temperature excursions without losing their required quality.

Real examples such as insulin, vaccines and biologic medicines show why storage conditions matter. Pharmaceutical stability testing and analytical testing show how manufacturers determine whether a product remains within specification.

For consumers, the practical rule is straightforward:

Follow the medicine’s labelled storage conditions. If a temperature excursion occurs, don’t guess—check the product-specific guidance or ask a pharmacist or manufacturer.

References

1. U.S. Food and Drug Administration (FDA). Expiration Dates — Questions and Answers. FDA. FDA: Expiration Dates — Questions and Answers
   Supports the discussion of expiration dating, stability, strength, quality, purity, and labelled storage conditions.
2. U.S. Food and Drug Administration (FDA). Expiration Dating and Stability Testing for Human Drug Products. FDA. FDA: Expiration Dating and Stability Testing for Human Drug Products
   Supports the discussion of temperature, humidity, controlled storage conditions, and stability testing.
3. International Council for Harmonisation (ICH). Q1A(R2): Stability Testing of New Drug Substances and Products. ICH. ICH Q1A(R2): Stability Testing of New Drug Substances and Products
   Supports the sections covering stability testing, stress testing, temperature, humidity, degradation pathways, and degradation products.
4. Centers for Disease Control and Prevention (CDC). Vaccine Storage and Handling. CDC. CDC: Vaccine Storage and Handling
   Supports the discussion of vaccine storage, potency, temperature excursions, temperature monitoring, and manufacturer-specific storage requirements.
5. Centers for Disease Control and Prevention (CDC). Vaccine Storage and Handling Toolkit. CDC, July 2026. CDC: Vaccine Storage and Handling Toolkit
   Supports the temperature ranges, monitoring, and temperature-excursion discussion for vaccines.
6. World Health Organization (WHO). Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns. WHO, 2013. WHO: MenAfriVac Controlled Temperature Chain Guidance
   Supports the MenAfriVac example concerning controlled exposure up to 40°C for up to four days under specified CTC conditions.

Medical Disclaimer

This article is for educational purposes only. It does not determine whether a specific medicine remains safe or effective after a storage or temperature excursion. For a medication that has been exposed to inappropriate temperature conditions, consult the product manufacturer, pharmacist, or appropriate healthcare professional for product-specific guidance.